Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Inovio Pharmaceuticals (INO)
NASDAQ:INO
Inovio Pharmaceuticals (INO) Stock Price & Analysis
5,465 Followers
INO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.55 - $2.82
Previous Close$0.58
Volume6.44M
Average Volume (3M)6.64M
Market Cap
$152.70M
Enterprise Value-$39.89M
Total Cash (Recent Filing)$223.75M
Total Debt (Recent Filing)$31.16M
Price to Earnings (P/E)-0.6
Beta1.93
Next Earnings
Aug 08, 2023EPS Estimate
-$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.98
Shares Outstanding262,740,113
10 Day Avg. Volume9,250,032
30 Day Avg. Volume6,644,166
Standard Deviation0.26
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.74
Price to Sales (P/S)1328.52
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-3.92
Enterprise Value/Gross Profit-3.89
Enterprise Value/Ebitda0.17
Forecast
1Y Price Target
$2.00Price Target Upside244.12% Upside
Rating ConsensusHold
Number of Analyst Covering2
Inovio Pharmaceuticals News
Pre-EarningsINO Upcoming Earnings Report: What to Expect?
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INO FAQ
What was Inovio Pharmaceuticals’s price range in the past 12 months?
Inovio Pharmaceuticals lowest stock price was $0.55 and its highest was $2.82 in the past 12 months.
What is Inovio Pharmaceuticals’s market cap?
Currently, no data Available
When is Inovio Pharmaceuticals’s upcoming earnings report date?
Inovio Pharmaceuticals’s upcoming earnings report date is Aug 08, 2023 which is in 61 days.
How were Inovio Pharmaceuticals’s earnings last quarter?
Inovio Pharmaceuticals released its earnings results on May 10, 2023. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.145 by -$0.015.
Is Inovio Pharmaceuticals overvalued?
According to Wall Street analysts Inovio Pharmaceuticals’s price is currently Undervalued.
Does Inovio Pharmaceuticals pay dividends?
Inovio Pharmaceuticals does not currently pay dividends.
What is Inovio Pharmaceuticals’s EPS estimate?
Inovio Pharmaceuticals’s EPS estimate is -$0.15.
How many shares outstanding does Inovio Pharmaceuticals have?
Inovio Pharmaceuticals has 262,740,100 shares outstanding.
What happened to Inovio Pharmaceuticals’s price movement after its last earnings report?
Inovio Pharmaceuticals reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.145. Following the earnings report the stock price went down -3.704%.
Which hedge fund is a major shareholder of Inovio Pharmaceuticals?
Among the largest hedge funds holding Inovio Pharmaceuticals’s share is Caxton Associates LP. It holds Inovio Pharmaceuticals’s shares valued at 643K.
---
Inovio Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.00 (244.12% Upside)
$2.00 (244.12% Upside)
Blogger Sentiment
Bullish
INO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 201.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.1%
Last 30 Days ▲ 4.0%
Last 30 Days ▲ 4.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.90%
12-Months-Change
Fundamentals
Return on Equity
-87.10%
Trailing 12-Months
Asset Growth
-40.16%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Inovio Pharmaceuticals
Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
---
Top 5 ETFs holding INO
Vanguard Health Care ETF
$667.31K
Fidelity Nasdaq Composite Index ETF
$219.35K
iShares NASDAQ US Biotechnology UCITS ETF
$63.48K
Invesco Nasdaq Biotechnology ETF
$2.66K
Up to five ETFs with an Outperform Smart Score that hold INO. The ETFs are listed according to market value of INO within the ETF
---
---